242 related articles for article (PubMed ID: 11134259)
21. Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.
Mohammad AJ; Weiner M; Sjöwall C; Johansson ME; Bengtsson AA; Ståhl-Hallengren C; Nived O; Eriksson P; Sturfelt G; Segelmark M
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i23-30. PubMed ID: 25540097
[TBL] [Abstract][Full Text] [Related]
22. Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.
Nachman PH; Segelmark M; Westman K; Hogan SL; Satterly KK; Jennette JC; Falk R
Kidney Int; 1999 Oct; 56(4):1544-50. PubMed ID: 10504506
[TBL] [Abstract][Full Text] [Related]
23. Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study.
Gregorini G; Ferioli A; Donato F; Tira P; Morassi L; Tardanico R; Lancini L; Maiorca R
Adv Exp Med Biol; 1993; 336():435-40. PubMed ID: 8296651
[TBL] [Abstract][Full Text] [Related]
24. Malignancy is increased in ANCA-associated vasculitis.
Pankhurst T; Savage CO; Gordon C; Harper L
Rheumatology (Oxford); 2004 Dec; 43(12):1532-5. PubMed ID: 15316126
[TBL] [Abstract][Full Text] [Related]
25. ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.
Campos MAG; Valois TO; Magalhães LE; Vasques LF; de Medeiros RG; Costa DMDN; Salgado Filho N; Nogueira RMDR; Neves PDMM; Silva GEB
Front Immunol; 2023; 14():1298622. PubMed ID: 38299140
[TBL] [Abstract][Full Text] [Related]
26. Silicon exposure and vasculitis.
Tervaert JW; Stegeman CA; Kallenberg CG
Curr Opin Rheumatol; 1998 Jan; 10(1):12-7. PubMed ID: 9448985
[TBL] [Abstract][Full Text] [Related]
27. Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy.
Turner-Stokes T; Wilson HR; Morreale M; Nunes A; Cairns T; Cook HT; Pusey CD; Tarzi RM; Lightstone L
Kidney Int; 2017 Nov; 92(5):1223-1231. PubMed ID: 28750930
[TBL] [Abstract][Full Text] [Related]
28. Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients.
Yin P; Li J; Wen Q; Qiu Y; Liang W; Wang J; Yu J; Zhong Z; Yang X; Yu X; Ye Q; Huang F
Ren Fail; 2020 Nov; 42(1):474-482. PubMed ID: 32406300
[No Abstract] [Full Text] [Related]
29. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
Heeringa P; Tervaert JW
Kidney Int; 2004 May; 65(5):1564-7. PubMed ID: 15086893
[TBL] [Abstract][Full Text] [Related]
30. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.
Falk RJ; Hogan S; Carey TS; Jennette JC
Ann Intern Med; 1990 Nov; 113(9):656-63. PubMed ID: 2221646
[TBL] [Abstract][Full Text] [Related]
31. ANCA vasculitis and IgA nephropathy linked to silica exposure.
Rao N; Bendall A; Lanteri M
Occup Med (Lond); 2020 Sep; 70(6):445-448. PubMed ID: 32678425
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis.
Chin HJ; Ahn C; Lim CS; Chung HK; Lee JG; Song YW; Lee HS; Han JS; Kim S; Lee JS
Am J Nephrol; 2000; 20(1):57-63. PubMed ID: 10644870
[TBL] [Abstract][Full Text] [Related]
33. "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome.
Charney DA; Nassar G; Truong L; Nadasdy T
Am J Kidney Dis; 2000 Jun; 35(6):1193-206. PubMed ID: 10845835
[TBL] [Abstract][Full Text] [Related]
34. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus.
Molnár K; Kovács L; Kiss M; Husz S; Dobozy A; Pokorny G
Clin Exp Dermatol; 2002 Jan; 27(1):59-61. PubMed ID: 11952673
[TBL] [Abstract][Full Text] [Related]
35. [Anti-neutrophil cytoplasmic antibodies ANCA in glomerulonephritis and systemic vasculitis with renal involvement--the frequency of occurrence and ability for granulocyte activation in vitro].
Mazanowska O; Klinger M; Wendycz-Domalewska D; Kopeć W
Pol Arch Med Wewn; 1998 May; 99(5):390-7. PubMed ID: 9816888
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients.
Szymczak M; Heidecke H; Żabińska M; Rukasz D; Wiśnicki K; Tukiendorf A; Krajewska M; Banasik M
Arch Immunol Ther Exp (Warsz); 2022 Sep; 70(1):23. PubMed ID: 36152104
[TBL] [Abstract][Full Text] [Related]
37. Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis.
Zhao MH; Liu N; Zhang YK; Wang HY
Nephrol Dial Transplant; 1998 Nov; 13(11):2821-4. PubMed ID: 9829484
[TBL] [Abstract][Full Text] [Related]
38. A case of infection-associated antiproteinase-3-negative cytoplasmic antineutrophil cytoplasmic antibody pauci-immune focal necrotizing glomerulonephritis.
Bell EK; Chugh SS; Cook WJ
Nephrol Dial Transplant; 2010 Sep; 25(9):3119-23. PubMed ID: 20566570
[TBL] [Abstract][Full Text] [Related]
39. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis.
Gómez-Puerta JA; Gedmintas L; Costenbader KH
Autoimmun Rev; 2013 Oct; 12(12):1129-35. PubMed ID: 23820041
[TBL] [Abstract][Full Text] [Related]
40. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
